You just read:

Final Phase III Study Results Reinforces Safety and Efficacy of Praxbind® as Reversal Agent for Pradaxa® Patients in Emergency Situations

News provided by

Boehringer Ingelheim Pharmaceuticals

Jul 11, 2017, 08:00 ET